Tag archive for ‘commercialization’
Eli Horn On Tuesday, January 20th, 2015

Billionaire Jim Breyer Extols ‘Magical’ Age of Innovative Thinking Worldwide

Experimentation and entrepreneurship taking place all over the globe are bringing new ideas and providing ways of overcoming economic stagnation, a Bloomberg report said. “Innovation is happening in centers More...

Gil Tanenbaum On Wednesday, January 7th, 2015

Gamida Cell Gets FDA Orphan Drug Approval

Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that orphan drug designation has been granted by the FDA for its investigational More...

Koby Yeshayahou On Sunday, December 21st, 2014

Medivation takes up $335 million Curetech licensing option

– The agreement gives Medivation the license to develop and commercialize Curetech’s pidilizumab cancer treatment. –   Medivation has decided to exercise the option granted it by Curetech More...

OPKO
Gali Weinreb On Tuesday, December 16th, 2014

Pfizer buys Israel-developed hormone drug from Opko

– Pfizer will pay $295 million for the growth hormone treatment and up to $275 million in milestone payments, and royalties. Pfizer Inc. (NYSE: PFE) has acquired the development and commercialization More...

Eli Horn On Monday, December 1st, 2014

Bank of England’s Deputy Chairman Bradley Fried Emphasizes Public Service, Support for Israel

  Bradley Fried, 49, could be described as the perfect antidote to the typically hard-nosed British financier. The Cape Town-born investor has a warm manner, infectious laugh and rarely wears a tie More...

Gil Tanenbaum On Friday, November 28th, 2014

Camtek 3D Tech Successfully Tested

Israel’s Camtek Ltd. announced that its 3D Functional InkJet Technology system for PCB solder mask applications, known as Gryphon, has successfully completed a beta testing phase at Eltek Ltd.’s More...

Gil Tanenbaum On Wednesday, October 29th, 2014

Medical Device Maker Endochoice Eyeing $150 Million IPO

Endochoice, a company which produces all manner of medical devices, is planning a NASDAQ IPO for 2015 which it hopes will bring in $100 to $150 Million. The firm merged with Israel’s endoscopic company More...

Gil Tanenbaum On Monday, October 27th, 2014

Clal Biotech Sells Pidilizumab Cancer Treatment Rights to Medivation

Israel’s Clal Biotechnology Industries has sold the exclusive worldwide commercialization rights for its cancer treatment pidilizumab to the American company Medivation. The rights are held by Clal subsidiary More...

Gil Tanenbaum On Wednesday, October 22nd, 2014

IonMed Gets Clearance for Post-Surgery Cold Plasma System

IonMed, an Israeli company that develops plasma-based technology, has received CE Mark clearance for its Bioweld1 cold plasma system for surgical incision closure. Israel is not just at the forefront of More...

Gil Tanenbaum On Monday, October 20th, 2014

Saskatchewan and Israel Increase Tech Ties

The Canada-Israel Industrial Research Development Foundation (CIIRDF), the Government of Saskatchewan, and the Embassy of Israel in Canada announced a new program to facilitate industry-led R&D collaboration More...

Wordpress site Developed by Fixing WordPress Problems